These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20648222)

  • 21. Assays of D-Amino Acid Oxidase Activity.
    Rosini E; Caldinelli L; Piubelli L
    Front Mol Biosci; 2017; 4():102. PubMed ID: 29404340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. D-Serine: Potential Therapeutic Agent and/or Biomarker in Schizophrenia and Depression?
    MacKay MB; Kravtsenyuk M; Thomas R; Mitchell ND; Dursun SM; Baker GB
    Front Psychiatry; 2019; 10():25. PubMed ID: 30787885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased D-amino acid oxidase expression in the bilateral hippocampal CA4 of schizophrenic patients: a post-mortem study.
    Habl G; Zink M; Petroianu G; Bauer M; Schneider-Axmann T; von Wilmsdorff M; Falkai P; Henn FA; Schmitt A
    J Neural Transm (Vienna); 2009 Dec; 116(12):1657-65. PubMed ID: 19823762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of isatin and 1H-indazol-3-ol derivatives as d-amino acid oxidase (DAAO) inhibitors.
    Szilágyi B; Kovács P; Ferenczy GG; Rácz A; Németh K; Visy J; Szabó P; Ilas J; Balogh GT; Monostory K; Vincze I; Tábi T; Szökő É; Keserű GM
    Bioorg Med Chem; 2018 May; 26(8):1579-1587. PubMed ID: 29472125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human d-amino acid oxidase: The inactive G183R variant.
    Murtas G; Caldinelli L; Cappelletti P; Sacchi S; Pollegioni L
    Biochim Biophys Acta Proteins Proteom; 2018 Jul; 1866(7):822-830. PubMed ID: 29274788
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dual role of D-amino acid oxidase in experimental pain models.
    Sharma J; Kulshrestha R; Singh N; Jaggi AS
    Eur J Pharmacol; 2019 Jul; 855():98-102. PubMed ID: 31059710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral administration of D-alanine in monkeys robustly increases plasma and cerebrospinal fluid levels but experimental D-amino acid oxidase inhibitors had minimal effect.
    Rojas C; Alt J; Ator NA; Wilmoth H; Rais R; Hin N; DeVivo M; Popiolek M; Tsukamoto T; Slusher BS
    J Psychopharmacol; 2016 Sep; 30(9):887-95. PubMed ID: 27287825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. No association of G72 and D-amino acid oxidase genes with schizophrenia.
    Liu YL; Fann CS; Liu CM; Chang CC; Wu JY; Hung SI; Liu SK; Hsieh MH; Hwang TJ; Chan HY; Chen JJ; Faraone SV; Tsuang MT; Chen WJ; Hwu HG
    Schizophr Res; 2006 Oct; 87(1-3):15-20. PubMed ID: 16842973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia.
    Yang CR; Svensson KA
    Pharmacol Ther; 2008 Dec; 120(3):317-32. PubMed ID: 18805436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1).
    Kapoor R; Lim KS; Cheng A; Garrick T; Kapoor V
    Brain Res; 2006 Aug; 1106(1):205-210. PubMed ID: 16828464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo pharmacological profile of AS057278, a selective d-amino acid oxidase inhibitor with potential anti-psychotic properties.
    Adage T; Trillat AC; Quattropani A; Perrin D; Cavarec L; Shaw J; Guerassimenko O; Giachetti C; Gréco B; Chumakov I; Halazy S; Roach A; Zaratin P
    Eur Neuropsychopharmacol; 2008 Mar; 18(3):200-14. PubMed ID: 17681761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and biochemical study of d-serine metabolism among schizophrenia patients.
    El-Tallawy HN; Saleem TH; El-Ebidi AM; Hassan MH; Gabra RH; Farghaly WM; Abo El-Maali N; Sherkawy HS
    Neuropsychiatr Dis Treat; 2017; 13():1057-1063. PubMed ID: 28435276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selenoprotein W as a molecular target of d-amino acid oxidase is regulated by d-amino acid in chicken neurons.
    Li W; Talukder M; Sun XT; Zhang C; Li XN; Ge J; Li JL
    Metallomics; 2018 May; 10(5):751-758. PubMed ID: 29766197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. d-Serine and d-Alanine Regulate Adaptive Foraging Behavior in
    Saitoh Y; Katane M; Miyamoto T; Sekine M; Sakai-Kato K; Homma H
    J Neurosci; 2020 Sep; 40(39):7531-7544. PubMed ID: 32855271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous synthesis of l-DOPA and oxidation of d-amino acid by specific coupling of a peroxidase to d-amino acid oxidase.
    Chen Y; Chu H; Liu W; Feng W
    Enzyme Microb Technol; 2019 Feb; 121():8-16. PubMed ID: 30554648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Competitive Inhibitors Unveil Structure/Function Relationships in Human D-Amino Acid Oxidase.
    Molla G
    Front Mol Biosci; 2017; 4():80. PubMed ID: 29250527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The D-amino acid oxidase inhibitor luvadaxistat improves mismatch negativity in patients with schizophrenia in a randomized trial.
    O'Donnell P; Dong C; Murthy V; Asgharnejad M; Du X; Summerfelt A; Lu H; Xu L; Wendland JR; Dunayevich E; Buhl DL; Litman R; Hetrick WP; Hong LE; Rosen LB
    Neuropsychopharmacology; 2023 Jun; 48(7):1052-1059. PubMed ID: 36928351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mouse strain specificity of DAAO inhibitors-mediated antinociception.
    Liu H; Zhou YC; Wang ZY; Gong N; Lu JM; Apryani E; Han QQ; Wang YX; Ou MX
    Pharmacol Res Perspect; 2021 Apr; 9(2):e00727. PubMed ID: 33710781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Controversial Effects of D-Amino Acid Oxidase Activator (DAOA)/G72 on D-Amino Acid Oxidase (DAO) Activity in Human Neuronal, Astrocyte and Kidney Cell Lines: The N-methyl D-aspartate (NMDA) Receptor Hypofunction Point of View.
    Jagannath V; Brotzakis ZF; Parrinello M; Walitza S; Grünblatt E
    Front Mol Neurosci; 2017; 10():342. PubMed ID: 29114206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Treatment for the Most Resistant Schizophrenia: Dual Activation of NMDA Receptor and Antioxidant.
    Lin CH; Chen YM; Lane HY
    Curr Drug Targets; 2020; 21(6):610-615. PubMed ID: 31660823
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.